Risk factors for failure of hydrostatic reduction of intussusception in pediatric patients: A retrospective study

Xie Xiaolong1, Wu Yang, Wang Qi

  • 1Department of Pediatric Surgery, West China Hospital, Sichuan University, China.

Medicine
|January 5, 2019
PubMed

Insights

Younger age, prolonged symptoms, rectal bleeding, constipation, and palpable masses are key risk factors for failed pediatric intussusception reduction. Understanding these indicators improves treatment outcomes for intussusception.

Area of Science:

  • Pediatric Gastroenterology
  • Surgical Outcomes Research

Background:

  • Intussusception is a common surgical emergency in infants and children.
  • Hydrostatic reduction is a primary non-operative treatment, but failure necessitates surgical intervention.

Purpose of the Study:

  • To identify significant risk factors associated with the failure of hydrostatic reduction in pediatric intussusception cases.
  • To inform clinical decision-making and potentially improve success rates of non-operative management.

Main Methods:

  • Retrospective analysis of pediatric patients (0-18 years) treated with hydrostatic reduction between 2010-2016.
  • Exclusion of patients with contraindications like peritonitis or shock.
  • Univariable and multivariable logistic regression analyses were performed on collected demographic, symptomatic, and clinical data.

Main Results:

  • Significant risk factors for failure included: age under 1 year (OR=3.915), symptom duration ≥48 hours (OR=0.056), rectal bleeding (OR=0.283), constipation (OR=0.086), palpable abdominal mass (OR=0.370), and left-over-right mass location (OR=13.782).
  • Multivariable analysis confirmed these factors' predictive value for hydrostatic reduction failure.

Conclusions:

  • Age, symptom duration, specific clinical signs (rectal bleeding, constipation, palpable mass), and mass location are critical predictors of hydrostatic reduction failure in pediatric intussusception.
  • Early recognition of these risk factors can guide timely surgical consultation and management planning.

Related Concept Videos

Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
13.5K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
259
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
304
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
223
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
292
Factors Affecting Protein-Drug Binding: Patient-Related Factors01:29

Factors Affecting Protein-Drug Binding: Patient-Related Factors

Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
323